- Home
- JKHY vs ICLR Comparison
JKHY vs ICLR Comparison
Compare JKHY & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JKHY | ICLR |
|---|---|---|
| Founded | 1976 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 15.1B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | JKHY | ICLR |
|---|---|---|
| Price | $183.04 | $188.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $192.36 | ★ $202.31 |
| AVG Volume (30 Days) | 575.4K | ★ 903.4K |
| Earning Date | 02-03-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.27% | N/A |
| EPS Growth | ★ 20.28 | N/A |
| EPS | 6.58 | ★ 7.47 |
| Revenue | $2,419,044,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $6.26 | $0.39 |
| P/E Ratio | $27.80 | ★ $25.08 |
| Revenue Growth | ★ 7.75 | N/A |
| 52 Week Low | $144.12 | $125.10 |
| 52 Week High | $196.00 | $211.00 |
Technical Indicators
Market Signals| Indicator | JKHY | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 45.57 | 53.68 |
| Support Level | $186.02 | $173.42 |
| Resistance Level | $190.17 | $190.21 |
| Average True Range (ATR) | 3.85 | 7.07 |
| MACD | -0.99 | -0.31 |
| Stochastic Oscillator | 25.32 | 49.47 |
Price Performance
Historical ComparisonAbout JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.